Published in Gene Therapy Weekly, February 21st, 2008
"The aim of this study was to evaluate the diagnostic and clinical significance of Survivin expression in hepatocellular carcinoma and non-neoplastic liver tissues in a series of surgical patients. Survivin mRNA levels were quantitated by real time RT-PCR in 25 patients. Survivin mRNA was documented in all liver tissues with significantly higher...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.